Table 2 Summary of complications and clinical outcomes for rAAA patients stratified by cTnI status
Outcome | All patients (n = 141) | cTnI (+) (n = 77) | cTnI (-) (n = 64) | P |
|---|---|---|---|---|
Congestive heart failure (n, %) | 41 (29.1) | 32 (41.6) | 9 (14.0) | <0.001 |
Cardiogenic shock (n, %) | 21 (14.9) | 20 (26.0) | 1 (1.6%) | <0.001 |
Acute kidney injury (n, %) | 98 (71.0) | 61 (82.4) | 37 (57.8) | 0.002 |
Renal replacement therapy (n, %) | 18 (13.3) | 15 (20.6) | 3 (4.8) | 0.01 |
LOS (d) hospital (med (IQR)) | 12 (8 to 20) | 12 (7 to 20) | 11 (9 to 19) | 0.84 |
LOS hospital (d) (survivors)* (med (IQR)) | 13 (10 to 22) | 16 (11 to 24) | 12 (9 to 17) | 0.02 |
LOS ICU (d) (med (IQR)) | 5 (2 to 11) | 8 (3 to 13) | 4 (2 to 9) | 0.03 |
LOS ICU (d) (survivors)* (med (IQR)) | 7 (3 to 11) | 8 (4 to 15) | 4 (2 to 9) | 0.002 |
ICU mortality (n, %) | 30 (21.4) | 24 (31.6) | 6 (9.4) | 0.01 |
In-hospital mortality (n, %) | 40 (28.3) | 31 (40.3) | 9 (14.1) | <0.001 |
1-year mortality (n, %) ( n = 139) | 48 (34.5) | 35 (46.7) | 13 (20.3) | 0.001 |